Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarkers Associated With Response to Natalizumab in Multiple Sclerosis Patients. A Prospective Multicentric Open Label Phase IV Study

NCT00942214 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT00942214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00942214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarkers Associated With Response to Natalizumab in Multiple Sclerosis Patients. A Prospective Multicentric Open Label Phase IV Study
Lead sponsor
University Hospital, Toulouse
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2009
Completion date
March 31, 2011
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis